Corporate_Investor_Kineticos Disruptor Fund
Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.